[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100574722":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":16,"locations":24,"responsibleParty":62,"collaborators":64,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":7,"enrollmentInfo":78,"targetDuration":81,"studyType":82,"phases":7,"briefSummary":83,"conditions":84,"keywords":87,"overallStatus":27,"whyStopped":7,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","OTHER",null,[9,13],{"name":10,"affiliation":11,"role":12},"Serena Di Cosimo, MD, PhD","Fondazione IRCCS Istituto Nazionale dei Tumori di Milano","PRINCIPAL_INVESTIGATOR",{"name":14,"affiliation":11,"role":15},"Paolo Verderio, PhD","STUDY_CHAIR",[17,21],{"name":10,"role":18,"phone":19,"phoneExt":7,"email":20},"CONTACT","+39 02 2390 2700","serena.dicosimo@istitutotumori.mi.it",{"name":14,"role":18,"phone":22,"phoneExt":7,"email":23},"+39 02 2390 3201","paolo.verderio@istitutotumori.mi.it",[25,45],{"facility":26,"status":27,"city":28,"state":7,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Ospedale Di Summa-Perrino","RECRUITING","Brindisi","72100","Italy","IT",{"type":33,"coordinates":34},"Point",[35,36],17.93607,40.63215,{"lat":36,"lon":35},[39,43],{"name":40,"role":18,"phone":41,"phoneExt":7,"email":42},"Saverio Cinieri, MD","+39 0831537217","saverio.cinieri@gmail.com",{"name":44,"role":12,"phone":7,"phoneExt":7,"email":7},"Laura Orlando, MD",{"facility":46,"status":27,"city":47,"state":7,"zip":48,"country":30,"countryCode":31,"cosmosGeoPoint":49,"geoPoint":53,"contacts":54},"Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale","Naples","80131",{"type":33,"coordinates":50},[51,52],14.26811,40.85216,{"lat":52,"lon":51},[55,60],{"name":56,"role":18,"phone":57,"phoneExt":58,"email":59},"Michelino De Laurentiis, MD","+39 081 7461111","+39 081590369","m.delaurentiis@istitutotumori.na.it",{"name":61,"role":12,"phone":7,"phoneExt":7,"email":7},"Roberta Caputo, MD",{"type":63,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[65,67],{"name":46,"class":66},"NETWORK",{"name":26,"class":68},"UNKNOWN","100574722","a-composite-assay-for-her2-positive-early-stage-breast-cancer-management-100574722",false,"NCT06762977","A Composite Assay for HER2-positive Early-stage Breast Cancer Management","HERCard","Inclusion Criteria:\n\n1. Age ≥ 18 years\n2. Operable breast cancer (stage I-III)\n3. Any status of hormone receptor in the primary tumor, according to institutional guidelines\n4. HER2-positive primary tumor, according to ASCO guidelines, i.e., HER2-positive phenotype by immunohistochemistry (IHC) 3+ or 2+ with a positive result for ERBB2 gene amplification analysis using ISH techniques (CISH, SISH, FISH)\n5. Neoadjuvant and\u002For adjuvant therapy based on trastuzumab ± pertuzumab\n6. Written informed consent from patients\n\nExclusion Criteria:\n\n1. Patient in follow-up for less than 3 years after surgery\n2. A prior diagnosis of invasive cancer before the diagnosis of breast cancer","ALL","18 Years",{"count":79,"type":80},180,"ESTIMATED","3 Years","OBSERVATIONAL","The goal of this observational study is to assess the prognostic value of a genomic classifier (S18) and its refined version (S\\*) in women with early-stage HER2-positive breast cancer. The study aims to determine whether these tools can predict event-free (EFS) and disease-free survival (DFS) in patients treated with neoadjuvant and\u002For adjuvant trastuzumab-based therapies.",[85,86],"Breast Cancer Early Stage Breast Cancer (Stage 1-3)","HER2",[88,89,90,91],"HER2-positive","operable breast cancer","gene-expression based classifier","prognosis","2025-01-07",{"date":94,"type":95},"2025-01-08","ACTUAL",{"date":97,"type":95},"2024-11-13",{"date":99,"type":80},"2026-08",{"name":5,"class":6},2]